Pfizer, Actavis End Patent Fight Over Generic Lipitor

Law360, Los Angeles (October 12, 2011, 3:13 PM EDT) -- A Delaware federal judge on Tuesday dismissed pharmaceutical giant Pfizer Inc.’s patent infringement suit against Iceland-based Actavis Group HF over a generic version of anti-cholesterol drug Lipitor, after the parties announced they had reached a settlement.

Tuesday's dismissal ends one of a series of patent suits brought by Pfizer over abbreviated new drug applications for generic Lipitor. Terms of the settlement were not immediately available.

New York-based Pfizer lodged a complaint alleging patent infringement in August 2010, after Actavis filed an ANDA seeking federal approval to...
To view the full article, register now.